Blood Collection Tube Market, By Product (Serum Tube, Plasma Tube, EDTA, Heparin, Coagulation, Glucose, Needle, Lancet, ESR, Syringe, and Blood Bag), By Application (Hospital, Blood Bank Center, Academics, and Home Care), By Method (Manual and Automated), By Region - Global Opportunity Analysis and Industry Forecast, 2020 – 2030

DFS020179  | 
: Life Sciences & Healthcare  | 
May-2024  | 
Upcoming  | 
Pages: NA  | 
Tables: NA  | 
Figures: NA
We’ve been tracking the direct impact of COVID-19 on this market, as well as the indirect impact from other industries. The report will incorporate these insights.

Blood Collection Tube Market has shown the growth of USD 5.1 billion in 2020 and is expected to grow by USD 8.8 billion by 2030, at an approximate CAGR of 5.7% during the forecasted period.Blood collection tubes are the devices that are used for collecting blood samples for performing laboratory diagnostic tests and treating patients. These devices are being used for specific cases like cancer therapies, accident victims, blood transfusions or transplantation and during the critical surgeries. The major uses of these tubes like in clinics, hospitals, blood banks, pathology laboratories, and multi-specialty hospitals have shown good growth and are expected to grow at a higher CAGR growth during the forecasted period.

Market Segmentation:

The global blood collection tube market is segmented by product into serum tube, plasma tube, EDTA, heparin, coagulation, glucose, needle, lancet, ESR, syringe, blood bag.  By application, the market is divided into hospitals, blood bank centers, academics, home care.  By the method, the market is bifurcated into manual, automated. By geography, the market is categorized into North America, Asia Pacific, Europe, and the ROW. 

Market Dynamics and Factors:

The increasing numbers of diseases like a growing number of surgeries, accidental, road accidents, sports injuries, and trauma are the prevailing factors for the growth of the blood collection tubes. Owing to the high costs of automated blood collection devices that costs between USD 1,000 and USD 3,000 have restrained the market growth. Technological advancements in blood collection procedures and products for critical diseases like Difficult Venous Access (DVA) have reduced the complicated procedures and further infection to cause amenia has given the opportunity to the growth of blood collection tubes. The lack of skilled professionals for operating advanced automated blood collecting devices will aff et the market growth in the future.

Geographic Analysis:

North America is the largest market and is also expected to dominate the market of global blood collection tube due to growth in the levels of awareness, advancements in blood collection technologies, rising prevalence of blood disorders, increasing demand for plasma from biopharmaceutical companies for plasma fractionation, government support, rising demand for apheresis initiatives for blood safety, and increasing prevalence of lifestyle diseases such as diabetes. The increasing adoption of automated blood collection devices has shown a boost in the North America region. For example, in 2015, according to the American Diabetes Association, 30.3 million people in the U.S. had diabetes which is 9.4 % of the total population. Moreover, countries such as India and China in the Asia Pacific region are expected to be the fastest-growing markets in this region owing to a large population base, improving healthcare infrastructure, increasing the number of hospitals, and growing medical tourism.

Competitive Scenario:

The major key players in the global blood collection tube market are Abbott, Biosigma, Becton, Dickinson & Company, Greiner Group AG, Sarstedt AG & Co., QIAGEN N.V., Terumo Corporation, and FL Medical SRL.

Blood Collection Tube Market Report Scope

Report Attribute

Details

Analysis Period

2020–2030

Base Year

2021

Forecast Period

2022–2030

Market Size Estimation

Billion (USD)

Growth Rate (CAGR%)

5.7 %

Market Segmentation:

By Product (Serum Tube, Plasma Tube, EDTA, Heparin, Coagulation, Glucose, Needle, Lancet, ESR, Syringe, and Blood Bag), By Application (Hospital, Blood Bank Center, Academics, and Home Care), By Method (Manual and Automated)

Geographical Segmentation

North America (U.S., Canada, Mexico) Europe (UK, Germany, Italy, France, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of APAC), South America (Brazil, Argentina, Rest of SA), MEA (UAE, Saudi Arabia, South Africa)

Key Companies Profiled

Abbott, Biosigma, Becton, Dickinson & Company, Greiner Group AG, Sarstedt AG & Co., QIAGEN N.V., Terumo Corporation, and FL Medical SRL.


TOC REQUEST


KEY MARKET SEGMENTS:

  • Global Blood Collection Tube Market – By Product
    • Serum Tube
    • Plasma Tube
    • EDTA
    • Heparin
    • Coagulation
    • Glucose
    • Needle
    • Lancet
    • ESR
    • Syringe
    • Blood Bag
  • Global Blood Collection Tube Market – By Application
    • Hospital
    • Blood Bank Center
    • Academics
    • Home Care
  • Global Blood Collection Tube Market – By Method
    • Manual
    • Automated
  • Global Blood Collection Tube Market – By Geography
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • U.K.
      • France
      • Germany
      • Italy
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • India
      • Australia
      • Rest of Asia Pacific
    • ROW
      • Latin America
      • Middle East
      • Africa

KEY PLAYERS
o    Abbott Laboratories
o    Biosigma
o    Becton
o    Dickinson & Company
o    Greiner Group AG
o    Sarstedt AG & Co.
o    QIAGEN N.V.
o    Terumo Corporation
o    FL Medical SRL.


 
©2024 Decision Foresight. All Rights Reserved.